Cerus (CERS) Short-Term Debt repayments (2012 - 2020)

Cerus' (CERS) quarterly Short-Term Debt repayments came in at $204000.0 in Q1 2020, down 70.18% quarter-over-quarter from $684000.0 in Q4 2012.

Cerus (CERS) Short-Term Debt repayments (2012 - 2020) Analysis & Trends

Cerus has disclosed Short-Term Debt repayments across 2 years of filings, most recently posting $204000.0 for Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Short-Term Debt repayments (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	-
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	259.00 Mn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	Cerus	496.03 Mn	416.34 Mn	27.89 Mn	-

Download Data